NLRP3 inflammasome inhibition by the novel bispecific antibody inflamab inhibits atherosclerosis in apolipoprotein E-deficient mice

Autor: Delfos, L., Depuydt, M.A.C., Foks, A., Kleijn, M. Bernabe, Kuiper, J., Chemaly, M., Peace, A., Mcgilligan, V., Bot, I.
Zdroj: In Atherosclerosis August 2023 379 Supplement 1:S2-S2
Databáze: ScienceDirect